Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,866Revenue $M2,877Net Margin (%)-12.0Altman Z-Score1.2
Enterprise Value $M20,035EPS $-4.9Operating Margin %-8.5Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-16.3Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %--Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow30.5y-y EBITDA Growth Rate %--ROA % (ttm)-3.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-12.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M179ROIC % (ttm)-9.1Gross Margin Increase y-yN

Gurus Latest Trades with NAS:ENDP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENDPSteve Mandel 2015-03-31 Buy 1.11%$71.97 - $92.37
($83.64)
$ 83.17-1%New holding3,270,117
ENDPGeorge Soros 2015-03-31 Add0.47%$71.97 - $92.37
($83.64)
$ 83.17-1%Add 26.79%2,217,176
ENDPWallace Weitz 2015-03-31 Reduce-0.04%$71.97 - $92.37
($83.64)
$ 83.17-1%Reduce 2.61%747,530
ENDPDodge & Cox 2015-03-31 Buy $71.97 - $92.37
($83.64)
$ 83.17-1%New holding2,560
ENDPMario Gabelli 2015-03-31 Reduce$71.97 - $92.37
($83.64)
$ 83.17-1%Reduce 26.38%14,650
ENDPGeorge Soros 2014-12-31 Buy 1.4%$60.19 - $73.37
($68.57)
$ 83.1721%New holding1,748,729
ENDPJulian Robertson 2014-12-31 Sold Out -0.37%$60.19 - $73.37
($68.57)
$ 83.1721%Sold Out0
ENDPJoel Greenblatt 2014-12-31 Sold Out -0.01%$60.19 - $73.37
($68.57)
$ 83.1721%Sold Out0
ENDPWallace Weitz 2014-09-30 Reduce-0.34%$61.26 - $70.27
($65.73)
$ 83.1727%Reduce 17.65%721,950
ENDPJoel Greenblatt 2014-09-30 Reduce-0.07%$61.26 - $70.27
($65.73)
$ 83.1727%Reduce 84.54%13,716
ENDPSteve Mandel 2014-06-30 Sold Out -1.2%$56.28 - $73.94
($66.81)
$ 83.1724%Sold Out0
ENDPWallace Weitz 2014-06-30 Add0.81%$56.28 - $73.94
($66.81)
$ 83.1724%Add 75.01%876,670
ENDPGeorge Soros 2014-06-30 Sold Out -0.13%$56.28 - $73.94
($66.81)
$ 83.1724%Sold Out0
ENDPJoel Greenblatt 2014-06-30 Buy 0.08%$56.28 - $73.94
($66.81)
$ 83.1724%New holding88,697
ENDPMario Gabelli 2014-06-30 Reduce$56.28 - $73.94
($66.81)
$ 83.1724%Reduce 21.77%23,900
ENDPJoel Greenblatt 2014-03-31 Sold Out -0.64%$64.3 - $81.49
($70.78)
$ 83.1718%Sold Out0
ENDPJulian Robertson 2014-03-31 Buy 0.51%$64.3 - $81.49
($70.78)
$ 83.1718%New holding22,800
ENDPGeorge Soros 2014-03-31 Buy 0.13%$64.3 - $81.49
($70.78)
$ 83.1718%New holding198,503
ENDPWallace Weitz 2014-03-31 Add0.12%$64.3 - $81.49
($70.78)
$ 83.1718%Add 12.33%500,920
ENDPDavid Dreman 2014-03-31 Sold Out -0.01%$64.3 - $81.49
($70.78)
$ 83.1718%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NAS:ENDP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NAS:ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer 2015-04-08Sell105,562$91.9-9.5view
Farhat CamillePresident, AMS, Inc. 2015-03-10Sell8,650$89.39-6.96view
Farhat CamillePresident, AMS, Inc. 2015-03-09Sell40,438$87.02-4.42view
MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer 2015-03-05Sell42,033$87.78-5.25view
Lortie BrianPresident Branded Pharma 2015-03-04Sell5,800$85.35-2.55view
Upadhyay SuketuEVP, CFO 2014-11-14Buy3,700$66.9424.25view
HIGGINS ARTHUR JDirector 2014-08-05Buy3,500$65.6526.69view
DELUCCA JOHNDirector 2014-06-09Sell6,764$68.8320.83view
MANOGUE CAROLINE BExec. V.P., CLO & Secy 2014-05-29Sell175,033$72.0215.48view
DELUCCA JOHNDirector 2014-05-01Sell8,094$66.3125.43view

Press Releases about NAS:ENDP :

    Quarterly/Annual Reports about NAS:ENDP:

      News about NAS:ENDP:

      Articles On GuruFocus.com
      Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
      Endo International Posts Upbeat Q1 Results May 13 2015 
      Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 
      Weitz Value Fund First Quarter 2015 Commentary Apr 20 2015 
      Weekly Insider Sells Highlight: ANTM, ENDP, QVCA, TOL Apr 12 2015 
      Valeant Finally Bags Salix for $11 Billion Apr 06 2015 
      This Week’s Pharma Highlights Mar 19 2015 
      Valeant Pharmaceuticals Goes Aggressive To Win Over Salix Mar 18 2015 
      Valeant Pharma Acquires Salix Mar 18 2015 
      Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 

      More From Other Websites
      No related articles found.

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

      GuruFocus Premium Plus Membership

      FEEDBACK